Esperion Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Esperion Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q1 2010 to Q2 2024.
  • Esperion Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 480M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 480M 0 0% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 480M +240M +100% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 480M +240M +100% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 480M +240M +100% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 480M +240M +100% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 240M +120M +100% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 240M +120M +100% Dec 31, 2022 10-K 2024-02-27
Q3 2022 240M +120M +100% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 240M +120M +100% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 120M 0 0% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 120M 0 0% Dec 31, 2021 10-K 2023-02-21
Q3 2021 120M 0 0% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 120M 0 0% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 120M 0 0% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 120M 0 0% Dec 31, 2020 10-K 2022-02-22
Q3 2020 120M 0 0% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 120M 0 0% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 120M 0 0% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 120M 0 0% Dec 31, 2019 10-K 2021-02-23
Q3 2019 120M 0 0% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 120M 0 0% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 120M 0 0% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 120M 0 0% Dec 31, 2018 10-K 2020-02-27
Q3 2018 120M 0 0% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 120M 0 0% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 120M 0 0% Mar 31, 2018 10-Q 2018-05-02
Q4 2017 120M 0 0% Dec 31, 2017 10-K 2019-02-28
Q3 2017 120M 0 0% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 120M 0 0% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 120M 0 0% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 120M 0 0% Dec 31, 2016 10-K 2018-02-20
Q3 2016 120M 0 0% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 120M 0 0% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 120M 0 0% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 120M 0 0% Dec 31, 2015 10-K 2017-02-22
Q3 2015 120M 0 0% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 120M 0 0% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 120M 0 0% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 120M 0 0% Dec 31, 2014 10-K 2016-02-25
Q3 2014 120M 0 0% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 120M 0 0% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 120M +61.8M +106% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 120M +70M +140% Dec 31, 2013 10-K 2015-03-10
Q3 2013 120M Sep 30, 2013 10-Q 2013-11-06
Q2 2013 120M Jun 30, 2013 10-Q 2013-08-12
Q1 2013 58.2M Mar 31, 2013 10-K 2014-03-13
Q4 2012 50M Dec 31, 2012 10-K 2014-03-13
Q4 2010 50M Jan 31, 2011 10-K 2014-03-13
Q1 2010 45M Apr 30, 2010 10-K 2014-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.